Jojo Densel Hammond, - Medicare Emergency Medicine in Appleton, WI

Jojo Densel Hammond, is a medicare enrolled "Emergency Medicine" physician in Appleton, Wisconsin. His current practice location is 1506 S Oneida St, Appleton, Wisconsin. You can reach out to his office (for appointments etc.) via phone at (920) 738-2100.

Jojo Densel Hammond is licensed to practice in Pennsylvania (license number MD442010) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1346414091.

Contact Information

Jojo Densel Hammond,
1506 S Oneida St,
Appleton, WI 54915-1305
(920) 738-2100
Not Available



Physician's Profile

Full NameJojo Densel Hammond
GenderMale
SpecialityEmergency Medicine
Location1506 S Oneida St, Appleton, Wisconsin
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1346414091
  • Provider Enumeration Date: 04/14/2008
  • Last Update Date: 06/01/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 8527246636
  • Enrollment ID: I20171011001684

Medical Identifiers

Medical identifiers for Jojo Densel Hammond such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1346414091NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207P00000XEmergency Medicine MD442010 (Pennsylvania)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Jojo Densel Hammond allows following entities to bill medicare on his behalf.
Entity NameAppleton Emergency Services Sc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1588666853
PECOS PAC ID: 4183517592
Enrollment ID: O20040207000109

News Archive

Keryx Biopharmaceuticals' perifosine receives FDA Fast Track Designation

Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for KRX-0401 (perifosine), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, for the treatment of refractory advanced colorectal cancer.

Microfluidic devices capture and analyze single cancer cells

One of the grand goals in nanotechnology is to develop a single microfluidic device that integrates all of the components needed to perform polymerase chain reaction (PCR)-based nucleic acid analyses. Experts predict that such a device would enable researchers to develop rapid assays for cancer and other life-threatening diseases while a patient is in the doctor's office.

Investigational drug provides no improved protection to patients with contrast-induced acute kidney injury

Patients treated with CMX-2043-an investigational drug that has previously shown some ability to protect heart muscle from damage during stenting-saw no improved protection in their kidneys compared to placebo, according to research presented at the American College of Cardiology's 65th Annual Scientific Session.

State highlights: Calif. gov. signs bills on prescription drug abuse; Texas groups sue over parts of abortion law; Calif.'s drug Medi-Cal program probed

Gov. Jerry Brown signed two bills Friday aimed at curbing prescription drug abuse but vetoed a third that could have helped the state's medical board identify reckless doctors whose patients died on pills they prescribed (Glover and Girion, 9/27).

European marine and algae oil omega-3 ingredient market to grow at 10% CAGR to reach $525.6M in 2013

The flood of scientific evidence on omega-3 eicosapentaenoic acid/docosahexaenoic acid (EPA/DHA) has significantly buoyed the credibility of polyunsaturated fatty acids (PUFAs) as vital functional ingredients. Heightened consumer awareness has had a telling effect on the healthy growth charts of the marine and algae oil omega-3 ingredients market.

Read more Medical News

› Verified 4 days ago

Entity NameEmergency Medicine Specialists Sc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1568413524
PECOS PAC ID: 8729975461
Enrollment ID: O20040228000032

News Archive

Keryx Biopharmaceuticals' perifosine receives FDA Fast Track Designation

Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for KRX-0401 (perifosine), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, for the treatment of refractory advanced colorectal cancer.

Microfluidic devices capture and analyze single cancer cells

One of the grand goals in nanotechnology is to develop a single microfluidic device that integrates all of the components needed to perform polymerase chain reaction (PCR)-based nucleic acid analyses. Experts predict that such a device would enable researchers to develop rapid assays for cancer and other life-threatening diseases while a patient is in the doctor's office.

Investigational drug provides no improved protection to patients with contrast-induced acute kidney injury

Patients treated with CMX-2043-an investigational drug that has previously shown some ability to protect heart muscle from damage during stenting-saw no improved protection in their kidneys compared to placebo, according to research presented at the American College of Cardiology's 65th Annual Scientific Session.

State highlights: Calif. gov. signs bills on prescription drug abuse; Texas groups sue over parts of abortion law; Calif.'s drug Medi-Cal program probed

Gov. Jerry Brown signed two bills Friday aimed at curbing prescription drug abuse but vetoed a third that could have helped the state's medical board identify reckless doctors whose patients died on pills they prescribed (Glover and Girion, 9/27).

European marine and algae oil omega-3 ingredient market to grow at 10% CAGR to reach $525.6M in 2013

The flood of scientific evidence on omega-3 eicosapentaenoic acid/docosahexaenoic acid (EPA/DHA) has significantly buoyed the credibility of polyunsaturated fatty acids (PUFAs) as vital functional ingredients. Heightened consumer awareness has had a telling effect on the healthy growth charts of the marine and algae oil omega-3 ingredients market.

Read more Medical News

› Verified 4 days ago

Entity NameAscension Calumet Hospital Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1376541748
PECOS PAC ID: 7416948427
Enrollment ID: O20040809000191

News Archive

Keryx Biopharmaceuticals' perifosine receives FDA Fast Track Designation

Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for KRX-0401 (perifosine), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, for the treatment of refractory advanced colorectal cancer.

Microfluidic devices capture and analyze single cancer cells

One of the grand goals in nanotechnology is to develop a single microfluidic device that integrates all of the components needed to perform polymerase chain reaction (PCR)-based nucleic acid analyses. Experts predict that such a device would enable researchers to develop rapid assays for cancer and other life-threatening diseases while a patient is in the doctor's office.

Investigational drug provides no improved protection to patients with contrast-induced acute kidney injury

Patients treated with CMX-2043-an investigational drug that has previously shown some ability to protect heart muscle from damage during stenting-saw no improved protection in their kidneys compared to placebo, according to research presented at the American College of Cardiology's 65th Annual Scientific Session.

State highlights: Calif. gov. signs bills on prescription drug abuse; Texas groups sue over parts of abortion law; Calif.'s drug Medi-Cal program probed

Gov. Jerry Brown signed two bills Friday aimed at curbing prescription drug abuse but vetoed a third that could have helped the state's medical board identify reckless doctors whose patients died on pills they prescribed (Glover and Girion, 9/27).

European marine and algae oil omega-3 ingredient market to grow at 10% CAGR to reach $525.6M in 2013

The flood of scientific evidence on omega-3 eicosapentaenoic acid/docosahexaenoic acid (EPA/DHA) has significantly buoyed the credibility of polyunsaturated fatty acids (PUFAs) as vital functional ingredients. Heightened consumer awareness has had a telling effect on the healthy growth charts of the marine and algae oil omega-3 ingredients market.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jojo Densel Hammond is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Jojo Densel Hammond,
1506 S Oneida St,
Appleton, WI 54915-1305

Ph: (920) 738-2100
Jojo Densel Hammond,
1506 S Oneida St,
Appleton, WI 54915-1305

Ph: (920) 738-2100

News Archive

Keryx Biopharmaceuticals' perifosine receives FDA Fast Track Designation

Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for KRX-0401 (perifosine), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, for the treatment of refractory advanced colorectal cancer.

Microfluidic devices capture and analyze single cancer cells

One of the grand goals in nanotechnology is to develop a single microfluidic device that integrates all of the components needed to perform polymerase chain reaction (PCR)-based nucleic acid analyses. Experts predict that such a device would enable researchers to develop rapid assays for cancer and other life-threatening diseases while a patient is in the doctor's office.

Investigational drug provides no improved protection to patients with contrast-induced acute kidney injury

Patients treated with CMX-2043-an investigational drug that has previously shown some ability to protect heart muscle from damage during stenting-saw no improved protection in their kidneys compared to placebo, according to research presented at the American College of Cardiology's 65th Annual Scientific Session.

State highlights: Calif. gov. signs bills on prescription drug abuse; Texas groups sue over parts of abortion law; Calif.'s drug Medi-Cal program probed

Gov. Jerry Brown signed two bills Friday aimed at curbing prescription drug abuse but vetoed a third that could have helped the state's medical board identify reckless doctors whose patients died on pills they prescribed (Glover and Girion, 9/27).

European marine and algae oil omega-3 ingredient market to grow at 10% CAGR to reach $525.6M in 2013

The flood of scientific evidence on omega-3 eicosapentaenoic acid/docosahexaenoic acid (EPA/DHA) has significantly buoyed the credibility of polyunsaturated fatty acids (PUFAs) as vital functional ingredients. Heightened consumer awareness has had a telling effect on the healthy growth charts of the marine and algae oil omega-3 ingredients market.

Read more News

› Verified 4 days ago


Emergency Medicine Doctors in Appleton, WI

Kirsten W Larson, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 3329 N Richmond Street, Appleton, WI 54911
Phone: 920-380-2715    
Michael D Polka, M.D.
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 1818 N Meade St, Appleton, WI 54911
Phone: 920-731-4101    
Cyril Walsh, MD
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 1818 N Meade St, Appleton, WI 54911
Phone: 800-968-6866    
Ryan J Wagner,
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 2400 E Capitol Dr, Appleton, WI 54911
Phone: 920-454-3300    Fax: 920-531-2098
Steven J Mcintyre, MD
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 1818 N Meade St, Appleton, WI 54911
Phone: 800-968-6866    
Kate Dobberstein,
Emergency Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 2105 E Enterprise Ave Ste 113, Appleton, WI 54913
Phone: 920-216-6171    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.